The diagnosis is clinical (see box 1). Restriction or pain, or both, on shoulder elevation and external rotation have been consistently described in the literature, 6 -12 yet there are insufficient data to evaluate diagnostic accuracy of signs and symptoms. 6 Restriction and pain are evident on passive as well as active testing, which differentiates it from rotator cuff disease (where passive movements are classically of full range). 6 Another differentiator is crepitus in the shoulder, which is more indicative of arthritis. 12 Three phases (pain, stiffness, and resolution) are described, but they often overlap. Patients may have pain-predominant or stiffness-predominant frozen shoulder. 13 Although frozen shoulder is considered self limiting, long term longitudinal follow-up data are scarce. The largest longitudinal series to date (223 patients) showed that 41% of patients had persistent symptoms at a mean follow up of 4.4 years, but this was based in secondary care, where more severe and less tractable cases are likely to be seen. 14 The same study found recurrence rare, but the other shoulder was affected in 6-17% of patients within five years. 14 Reported associations include diabetes, cardiovascular disease, trauma, stroke, neurosurgery, and thyroid disease. 5 Less invasive treatments are generally tried first, but earlier use of more invasive interventions, particularly surgical capsular release, is increasing (box 2). 18 There is uncertainty as to when these should be offered, and their clinical and cost effectiveness.
What is the evidence of uncertainty?
There are large gaps in evidence for effectiveness of treatments for frozen shoulder. The systematic review we analysed (see box 3) included 28 randomised controlled trials, one quasi-experimental study, and two case series. 15 There were insufficient studies with a similar intervention and comparator to quantify effectiveness. Most studies are at a high risk of bias; do not report adequate methods for randomisation, allocation concealment, and outcome assessment; and seem to be inadequately powered. Few studies report a consistent method for collection of data on harms. 15 Overall, physiotherapy and intra-articular steroid injections have been shown to have some benefit. Although there is no convincing evidence to support other measures, we emphasise the absence of good evidence rather than evidence that these management options are ineffective (see table 1 ).
A systematic review of six randomised controlled trials comparing intra-articular corticosteroid injection with placebo and with manual therapy and exercise shows short term benefit with improvement in pain, function, and range of movement (up to 6-7 weeks) compared with placebo 15 and possibly compared with manual therapy and exercise. 19 This evidence suggests that a single corticosteroid injection for people with frozen shoulder of up to a year in duration may hasten improvements in pain and function by some weeks. There is moderate evidence for hydrodilatation distension of the 
Box 3: Search strategy and study selection
We have referenced the most up to date systematic review, published in 2012, for individual treatment comparisons. 15 We searched Medline for randomised controlled trials undertaken since then (up to May 2015) using the search strategy from the 2012 review combined with a validated filter for randomised controlled trials. We screened the results for new trials of manipulation under anaesthesia, capsular distension, and capsular release only, as physiotherapy interventions had been studied in Cochrane reviews published in 2014.
shoulder capsule with normal saline and corticosteroid instead of a corticosteroid injection. 15 Exercise and mobilisation may augment the effect of steroid injection for some outcomes, but there is insufficient evidence to reach a conclusion.
Designing trials and quantifying the efficacy of physiotherapy is fraught with difficulty. It is a complex intervention encompassing a range of physical techniques, advice, education, painkillers, thermal or electrotherapy, and steroid injection that may have varying efficacy and may be delivered in varying intensities. 8 9
Our updated Medline searches identified: A randomised trial of 64 patients comparing fluoroscopy guided anterior distension with ultrasonography guided posterolateral capsular distension 21 A randomised trial of 48 patients comparing ultrasonography guided and fluoroscopy guided capsular distension 22
A four-armed study with 53 participants investigating intensive mobilisation techniques combined with capsular distension. 23
All the studies had a high risk of bias and seem to be inadequately powered.
Is ongoing research likely to provide relevant evidence?
We searched http://clinicaltrials.gov and the WHO International Clinical Trials Registry Platform and identified six ongoing randomised trials (table 2 ) . These trials are likely to provide evidence on four commonly used current interventions that is, intra-articular injection with physiotherapy, hydrodilatation, manipulation under anaesthesia, and capsular release.
What should we do in light of the uncertainty?
Communicate to patients that frozen shoulder is a benign and usually self limiting condition. Simple advice on activity modification and pain control may suffice (see box 4). Listen to the patient, and be prepared to adapt treatment, for example by referring on if their symptoms are not resolved or if the diagnosis is in doubt.
Consider referral for physiotherapy. Based on a survey of 289 UK physiotherapists, 16 physiotherapy care for frozen shoulder includes advice and education, which patients consider crucial. 30 In the pain-predominant stage, it is also likely to include an intra-articular steroid injection, a technique practised by many physiotherapists, and for which there is moderate evidence of effectiveness.
Current trends in practice involve escalation to more invasive treatments including manipulation under anaesthesia or arthroscopic capsular release, but there is insufficient evidence to recommend these. The pain slowly eases, but stiffness increases, becoming the main problem, before gradually resolving.
The whole process may last from a few months to two to three years, but the pain does not last for the whole time.
How can you help yourself?
When in pain, the emphasis is on pain relief and gentle use of your arm to ease spasm and maintain movement.
Using your arm will not do any harm, but avoid aggravating your pain by doing too much. Take pain medication as advised. You may find hot packs helpful.
In bed, support the arm with pillows as a reminder not to roll onto it.
As time passes you will feel less need for pain relief.
What are the common treatments?
Treatments other than pain medication are not always needed; but steroid injections are often used to reduce inflammation and pain in the shoulder, and physiotherapy may help to diminish pain and restore movement.
A minority of people are referred to hospital with frozen shoulder, where additional options include release of the tight tissues by an injection or by keyhole surgery.
It remains unclear which options are most effective. You should discuss treatment options with your clinician, based on your needs and preferences.
To address these uncertainties, it would be appropriate to encourage suitable patients to participate in trials designed to answer questions on which treatments are most effective (box 5).
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How patients were involved in the creation of this article
We asked two patients with frozen shoulder to comment on the manuscript and incorporated their suggestions. They firmly endorsed individualised strategies over rigid pathways in management of symptoms. A patient contributor also recommended further research on effectiveness of a structured multidisciplinary approach with early involvement of general practitioner, orthopaedic surgeon or rheumatologist, physiotherapist, and pain management specialist. 
